首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 109 毫秒
1.
以对硝基苯肼为起始原料,采用费舍尔吲哚合成法合成中间体5-硝基吲哚-2-羧酸酯(3),经还原合成5-氨基吲哚-2-羧酸酯(4),再与4-甲氧基-2-甲苯基异氰酸酯合成脲(5),(5)在水合肼作用下5-(3-(4-甲氧基-2-甲苯基)脲基)-1H-吲哚-2-碳酰肼(6),化合物6和取代醛反应,合成了6个2,5-二取代吲哚衍生物(7a~7f),其结构经~1HNMR,~(13)CNMR和HR-MS表征。采用MTT法研究了7a~7f对人肺癌细胞(A549)和人肝癌细胞(HepG-2)的体外抗增殖活性。结果显示:7d体外抑制活性最优,其IC_(50)分别为10.35μmol·L~(-1)、12.60μmol·L~(-1)。  相似文献   

2.
以炔基苯衍生物为原料,通过钯催化C-N偶联合成一系列2,3-二取代吲哚衍生物。实验优化表明,最佳实验条件如下:以3 mol%当量Pd(OAc)_2及6 mol%当量PPh_3作为联合催化剂,1倍当量的底物和1.1倍当量的溴苯衍生物在含有2倍当量的有机碱正三丁胺的DMF溶剂中,于120℃下反应10小时。产物结构经~1H NMR、~(13)C NMR、HRMS分析确证,其中化合物2a经X射线单晶衍射分析确证。  相似文献   

3.
阮铱瞳  何菱 《合成化学》2020,28(5):410-415
基于醌类以及含"2-苯基萘型"结构单元的衍生物在临床上表现出良好的抗肿瘤活性,设计了取代吲哚苯醌衍生物。以2-取代吲哚衍生物为底物,乙腈为反应溶剂,在相转移催化剂苄基三乙基氯化铵和无水碳酸钾存在下,与四溴苯醌反应,合成了9个未见文献报道的2-取代吲哚-1,4-醌衍生物(2a^2c,3a^3c,4a^4c),其结构经1H NMR,13C NMR和HR-MS(ESI)表征。体外抗肿瘤活性实验表明,该类化合物对人肺癌细胞系(A549)、人乳腺癌细胞系(MDA-MB-231)及宫颈癌细胞系(Hela)具有抑制作用,其中化合物2b和3c对人乳腺癌细胞系MDA-MB-231具有良好的抑制活性。  相似文献   

4.
为了寻找高效低毒的抗肿瘤药物,设计并合成新型的1,3位取代酞嗪酮类化合物.采用噻唑蓝(MTT)法对目标化合物在MCF-7(人乳腺癌细胞)、PC-3(人前列腺癌细胞)、SW-620(人结肠癌细胞)和HGC-27(人胃癌细胞)四种人类癌细胞的抗增殖活性进行评价.结果显示大部分化合物具有较好的抗增殖活性.其中,2-(4-(4-溴苯基)-1-氧代酞嗪-2(1H)-基)-N-(2-氟苯基)乙酰胺(5g)对MCF-7细胞的抗增殖活性较好,IC50值为6.01μmol/L,为抗肿瘤药物的研究提供了思路.  相似文献   

5.
以3-氯氧化吲哚为原料,在无催化剂条件下发生SN1反应,合成了18个新型的3-吲哚-四取代氧化吲哚,产率34%~77%,其结构经1H NMR, 13C NMR和HR-MS(ESI-TOF)表征。  相似文献   

6.
以对硝基苯肼为起始原料,采用费舍尔吲哚合成法合成中间体5-硝基吲哚-2-羧酸酯(3),经还原合成5-氨基吲哚-2-羧酸酯(4),再与氯甲酸苯酯合成酰胺(5),5在水合肼作用下形成2,5-碳酰肼吲哚(6),化合物6和取代醛反应,合成了7个2,5-二取代吲哚碳酰肼衍生物(7a~7g)。目标化合物经~1HNMR、~(13)CNMR、HR-MS结构确证。采用MTT法研究了目标化合物的细胞毒活性。结果显示,目标化合物对所选肿瘤细胞的增殖活性具有一定抑制作用。其中7c对宫颈癌细胞(Hela)、乳腺癌细胞(MCF-7)和人肝癌细胞(HepG-2)的抑制活性与阳性药顺铂活性相近。  相似文献   

7.
吲哚是一种自然界中广泛存在的化合物,具有抗肿瘤、抗氧化、抗菌等生物活性。在吲哚3-位引入不同的取代基,进行结构的修饰与改造一直是药物研究的热点。本文归纳总结了近年来相关的文献,对吡唑及吡唑啉类、二唑及三唑类、与2-位成环类等不同杂环取代的3-取代吲哚衍生物的抗肿瘤活性进行系统性的综述,以期为高活性抗肿瘤药物的研发提供一定的理论基础。  相似文献   

8.
本文以吲哚骨架为起点,设计合成了5个含吲哚骨架的新型有机小分子(4a-4e),通过NMR,IR和MS对目标化合物进行了结构表征.采用MTS法测试了目标化合物对SMMC-7721,Hela,MCF-7和HepG2癌细胞的体外抗肿瘤活性.结果表明,部分化合物选择性地作用于一种细胞,显示出较强的抑制肿瘤细胞增殖的活性,值得进一步研究.  相似文献   

9.
以吲哚-3-甲酸甲酯为原料,通过肼解、环合生成5-(1H-吲哚3-基)-1,3,4-噁二唑-2-硫醇,再对其进行亲核取代和氧化反应得到目标化合物,并通过1H NMR、13C NMR和HRMS确认其结构。采用噻唑蓝(MTT)法测试了目标化合物对几种癌细胞的体外抑制活性,同时采用比浊法对几种植物病原菌进行了体外抑菌活性测试。结果表明,化合物对于A549(人肺癌细胞)、PC-3(人前列腺癌细胞)、K562(人慢性髓原白血病细胞)和HepG2(人肝癌细胞)四种癌细胞有一定的抑制活性;对水稻白叶枯病菌(Xanthomonas oryzae pv.oryzae,Xoo)、柑橘溃疡病菌(Xanthomonas axonopodis pv.citri,Xac)以及猕猴桃溃疡病菌(Pseudomonas syringae pv.actinidiae,Psa)三种植物病菌同样具有一定的抑菌活性。其中,化合物4f对Xoo的体外抑制率可达87.09%(100μg/mL)和54.02%(50μg/mL)。本文结果可为具有砜结构的吲哚衍生物的合成及应用研究提供参考。  相似文献   

10.
3,3-二甲基-2-(3-甲基薁乙烯基)-3H-吲哚衍生物的合成   总被引:1,自引:1,他引:0  
1-甲酰基薁-3-甲酸甲酯和2,3,3-三甲基-3H-吲哚衍生物发生缩合反应,合成了一系列3,3-二甲基-2-(3-甲基薁乙烯基)-3H-吲哚衍生物,收率48%~64%,其结构经~1H NMR,IR和元素分析表征.  相似文献   

11.
A new series of hybrid molecules containing cinnamic acid and 2-quinolinone derivatives were designed and synthesized. Their structures were confirmed by 1H-NMR, 13C-NMR and mass analyses. All the synthesized hybrid molecules were assessed for their in vitro antiproliferative activity against more than one cancer cell lines. Compound 3-(3,5-dibromo-7,8-dihydroxy-4-methyl-2-oxoquinolin-1(2H)-ylamino)-3-phenylacrylic acid (5a) with IC50 = 1.89 μM against HCT-116 was proved to the most potent compound in this study, as compared to standard drug staurosporin. DNA flow cytometry assay of compound 5a revealed G2/M phase arrest and pre-G1 apoptosis. Annexin V-FITC showed that the percentage of early and late apoptosis was increased. The results of topoisomerase enzyme inhibition activity showed that the hybrid molecule 5a displays potent inhibitory activity compared with control.  相似文献   

12.
A convenient synthesis of 1-alkyl-2-chloro-1H-indole-3-carbaldehyde oximes(5a―5d) and 1-alkyl-2-phenoxy-1H-indole-3-carbaldehyde oximes(6a―6d) from 2-indolone was completed via the Vilsmeier-Haack reac-tion,with N-alkylation and oximation as the key steps.An improved one-pot method for the synthesis of 1-alkyl-2-alkoxy-1H-indole-3-carbaldehyde oximes(7a―7h) from 1-alkyl-2-chloro-1H-indole-3-carbaldehydes(3a―3d) was described.The Williamson reactions and esterification reactions were performed and the oxime-...  相似文献   

13.
The non-isolated adducts (3a,b) were used as key intermediates to synthesize some novel thiazolidine and thiophene derivatives. Compound (4) exhibited a remarkable antitumor activity against EAC cells compared with the Doxorubicin as a positive control.  相似文献   

14.
The reaction of 3‐benzoylcyanomethylidine‐1(H)‐indole‐2‐one ( 1 ) with a variety of active methylene compounds, thioglycolic acid, glycine, hydrazine hydrate and phenyl hydrazine led to the formation of compounds 4a‐d‐10 . 3‐Thiosemicarbazide‐1(H)‐indole‐2‐one 2 on reaction with α‐halocarbonyl compounds gave compounds 11a‐c, 12a‐c . The latter compounds on heating with phosphoryl chloride, cyclization takes place via losing water to give the angular tetracyclic compounds 13a,b and 14a‐c . Cyanoacetic hydrazone derivative 3 readily cyclized upon heating in triethyl orthoformate to give the tricyclic system, oxopyridazino indole 15 . On the other hand, the reaction of 3 with benzylidine malononitrile and benzylidene ethylcyanoactate gave the pyranyl hydrazone derivatives 16a,b .  相似文献   

15.
Summary.  Various sulfa drugs were condensed with 4-isothiocyanato-4-methyl-2-pentanone at pH∼3–5 by refluxing in methanol to give various substituted mercaptopyrimidines. On condensation with 9-chloro-2-substituted or -unsubstituted acridines, sulfathiazole gave the corresponding condensed products. N-Ethylaminoadenosine reacted with 9-chloroacridine to the coupled product. Condensation of sulfathiazole with 9-isothiocyanato-2,4-substituted or -unsubstituted acridines afforded the corresponding condensed compounds. The structures of all synthesized compounds were confirmed by spectroscopic methods. Anticancer, antiinflammatory, and analgesic activities of all compounds were investigated. Received November 18, 1999. Accepted (revised) January 12, 2000  相似文献   

16.
2-(2-Cyano-acetylamino)-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxamide(3) was used as starting material for synthesis of 4-thiazolidinone, thiazolidine, and thiophene derivatives 6, 7a, b, and 8a, b, respectively. Thiocarbomyl derivative 5, 4-thizolidinone 9, and thioxothiazolidine 10 were obtained from reaction of 3 with thioglycolic acid and phenyl isothiocyanate/sulfur, respectively. Condensation of 3 with selected cyclic ketones and aromatic aldehydes yielded the arylidine derivatives 11a, b and 13, respectively. Refluxing of 11a, b with sulfur and morpholine yielded the thiophene derivatives 12a, b, respectively. Diazocoupling of compound 3 withp-tolyl diazonium chloride yielded the hydrazone derivative 14. The newly synthesized compounds were characterized by infrared, 1H NMR, and mass spectral studies. Representative compounds of the synthesized product were tested and evaluated as antimicrobial agents. Compound 12b gives very high antimicrobial activity against Ampicillin.  相似文献   

17.
於祥  陈娅芳 《化学通报》2018,81(7):657-659
本文报道了一种通过微波辅助合成5-亚甲基-2,3-二苯基-4-噻唑酮类衍生物的新型方法。在以K2CO3 为碱、H2O 为溶剂、四丁基溴化铵(TBAB)为催化剂的条件下,2,3-二苯基-4-噻唑酮与取代醛在微波辅助下发生Knoevenagel 反应,生成5-亚甲基-2,3-二苯基-4-噻唑酮类衍生物,产率最高可达85%。  相似文献   

18.
2, 5-二取代基-1, 3, 4-恶二唑及恶二唑啉类化合物的合成   总被引:40,自引:0,他引:40  
2-苯基-1,2,3-连三唑-4-甲酰肼(1)与芳酸在POCl~3催化下得到6种新的2-芳基-5-(2'-苯基-1',2',3'-连三唑-4'-基)-1,3,4-恶二唑(2)。1与羰基化合物缩合得到相应的酰腙(3),在Ac~2O作用下环化成2-取代基-3-乙酰基-5-(2'-苯基-1',2',3'-连三唑-4'-基)-1,3,4-恶二唑啉(4)。化合物的结构经元素分析,IR,^1HNMR和MS确证。  相似文献   

19.
依据生物电子等排原理,设计合成了13个全新结构的1,2-苯并噻嗪类化合物,其结构均经IR,1H NMR,13C NMR和MS确证.以A431,A549,MDA-MB-468和HL60 4种细胞株为活性筛选对象,采用四甲基偶氮唑盐(MTT)法进行初步的体外抗肿瘤活性研究.结果表明,部分化合物对肿瘤细胞有一定的抑制活性,其中化合物5b对A431具有显著的抑制活性,IC50值为1.57μmol/L,化合物9a对A431,A549和MDA-MB-468 3种细胞株的抑制活性均强于阳性对照药gefitinib.并采用Moe软件对所合成的化合物与表皮生长因子受体(EGFR)结合位点进行对接,以进一步阐释所合成化合物的作用靶标.  相似文献   

20.
An efficient synthesis of 2, 3-disubstituted indole derivatives through low-valent titanium induced reductive cyclization of acylamido carbonyl compounds is described.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号